Providing patient in community in Australia

Benrimoj, SI; Roberts, AS

Providing patient in community in Australia

Benrimoj, SI

Roberts, AS

Permalink

Publication Type:: Journal Article
Citation:: Annals of Pharmacotherapy, 2005, 39 (11), pp. 1911 - 1917
Issue Date:: 2005-11-01

Closed Access

	Filename	Description	Size
	2010000839OK.pdf		65.63 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Benrimoj, SI https://orcid.org/0000-0001-9768-7838	en_US
dc.contributor.author	Roberts, AS	en_US
dc.date.issued	2005-11-01	en_US
dc.identifier.citation	Annals of Pharmacotherapy, 2005, 39 (11), pp. 1911 - 1917	en_US
dc.identifier.issn	1060-0280	en_US
dc.identifier.uri	http://hdl.handle.net/10453/16880
dc.description.abstract	OBJECTIVE: To describe Australia's community pharmacy network in the context of the health system and outline the provision of services. DATA SYNTHESIS: The 5000 community pharmacies form a key component of the healthcare system for Australians, for whom health expenditures represent 9% of the Gross Domestic Product. A typical community pharmacy dispenses 880 prescriptions per week. Pharmacists are key partners in the Government's National Medicines Policy and contribute to its objectives through the provision of cognitive pharmaceutical services (CPS). The Third Community Pharmacy Agreement included funding for CPS including medication review and the provision of written drug information. Funding is also provided for a quality assurance platform with which the majority of pharmacies are accredited. Fifteen million dollars (Australian) have been allocated to research in community pharmacy, which has focused on achieving quality use of medicines (QUM), as well as developing new CPS and facilitating change. Elements of the Agreements have taken into account QUM principles and are now significant drivers of practice change. Although accounting for 10% of remuneration for community pharmacy, the provision of CPS represents a significant shift in focus to view pharmacy as a service provider. Delivery of CPS through the community pharmacy network provides sustainability for primary health care due to improvement in quality presumably associated with a reduction in healthcare costs. CONCLUSIONS: Australian pharmacy practice is moving strongly in the direction of CPS provision; however, change does not occur easily. The development of a change management strategy is underway to improve the uptake of professional and business opportunities in community pharmacy.	en_US
dc.relation.ispartof	Annals of Pharmacotherapy	en_US
dc.relation.isbasedon	10.1345/aph.1G165	en_US
dc.subject.classification	Pharmacology & Pharmacy	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Patient Care	en_US
dc.subject.mesh	Pharmacies	en_US
dc.subject.mesh	Community Pharmacy Services	en_US
dc.subject.mesh	Australia	en_US
dc.title	Providing patient in community in Australia	en_US
dc.type	Journal Article
utslib.citation.volume	11	en_US
utslib.citation.volume	39	en_US
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
dc.location.activity	Istanbul, Turkey
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	closed_access
pubs.issue	11	en_US
pubs.publication-status	Published	en_US
pubs.volume	39	en_US

Abstract:

OBJECTIVE: To describe Australia's community pharmacy network in the context of the health system and outline the provision of services. DATA SYNTHESIS: The 5000 community pharmacies form a key component of the healthcare system for Australians, for whom health expenditures represent 9% of the Gross Domestic Product. A typical community pharmacy dispenses 880 prescriptions per week. Pharmacists are key partners in the Government's National Medicines Policy and contribute to its objectives through the provision of cognitive pharmaceutical services (CPS). The Third Community Pharmacy Agreement included funding for CPS including medication review and the provision of written drug information. Funding is also provided for a quality assurance platform with which the majority of pharmacies are accredited. Fifteen million dollars (Australian) have been allocated to research in community pharmacy, which has focused on achieving quality use of medicines (QUM), as well as developing new CPS and facilitating change. Elements of the Agreements have taken into account QUM principles and are now significant drivers of practice change. Although accounting for 10% of remuneration for community pharmacy, the provision of CPS represents a significant shift in focus to view pharmacy as a service provider. Delivery of CPS through the community pharmacy network provides sustainability for primary health care due to improvement in quality presumably associated with a reduction in healthcare costs. CONCLUSIONS: Australian pharmacy practice is moving strongly in the direction of CPS provision; however, change does not occur easily. The development of a change management strategy is underway to improve the uptake of professional and business opportunities in community pharmacy.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/16880